SBC Stock Analysis: Buy, Sell, or Hold?
SBC - SBC Medical Group Holdings Incorporated Common Stock
$4.18
0.09 (2.20%)
▲
5d:
+8.29%
30d:
+7.18%
90d:
-4.78%
BUY
MODERATE Confidence
Analysis Updated: Mar 31, 2026 12:00 AM ET
Earnings: May 14, 2026
Get Alerted When SBC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: SBC shows positive signals but monitor for confirmation. Market pricing in 4.6% decline. Moderate conviction.
💡 BUY OPPORTUNITY: SBC shows positive signals but monitor for confirmation. Market pricing in 4.6% decline. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$7.85
Based on 10.4% avg growth
INTRINSIC VALUE TODAY
$4.87
14.2% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 8.6x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: SBC is currently trading at $4.18, which is considered extended relative to its 30-day fair value range of $3.62 to $4.01. From a valuation perspective, the stock is trading at a discount (Forward PE: 7.5) compared to its historical average (8.6). Remarkably, the market is currently pricing in an annual earnings decline of 4.6% over the next few years. This pessimistic expectation contrasts with the company's recent 117.5% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, SBC is in a uptrend. The price is approaching resistance at $4.20. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: SBC has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $8.12 (+94.4%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, SBC is in a uptrend. The price is approaching resistance at $4.20. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: SBC has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $8.12 (+94.4%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Fair Price Range
$3.62 -
$4.01
Company Quality Score
61/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
61.9%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 94.4% below Wall St target ($8.12)
Fair Price Analysis
30-Day Fair Range
$3.62 -
$4.01
Current vs Fair Value
EXTENDED
Support & Resistance Levels
Support Level
$3.49
Resistance Level
$4.20
Current Trend
Uptrend
Technical data as of
Mar 31, 2026
Fundamental Context
Forward P/E (Next Year Est.)
7.46
Wall Street Target
$8.13
(+94.4%)
Revenue Growth (YoY)
-10.9%
Earnings Growth (YoY)
117.5%
Profit Margin
29.4%
Valuation Discount vs History
-4.6% cheaper
PE vs Historical
7.5 vs 8.6
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-4.6%
(market-implied from PE analysis)
1-Year Target
$3.99
(-5%)
2-Year Target
$3.80
(-9%)
3-Year Target
$3.63
(-13%)
3-Yr Target (if PE normalizes)
(PE: 7→9)
$4.18
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.4, Growth: 16.7%)
$19.87
(+376%)
Base:
(SPY PE: 7.5, Growth: 16.7%)
$6.64
(+59%)
Bear:
(PE: 6.3, Growth: 16.7%)
$5.64
(+35%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (9x PE), but valuation improves significantly next year (7x PE) as earnings recover.
Trailing PE: 8.81 | Current EPS (TTM): $0.42
Bull Case
$4.65
(+19%)
Analyst growth 14.3%, PE expands to 9.7
Base Case
$4.23
(+8%)
Market implied 14.3%, PE stable at 8.8
Bear Case
$2.52
(-36%)
Severe decline -20.0%, PE contracts to 7.5
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 7.5 to 8.6
Stabilization Target:
$4.82
(+15.2%)
PE Expansion Potential:
+15.2%
Share & Embed Analysis
Last updated: March 31, 2026 6:50 PM ET
Data refreshes hourly during market hours. Next update: 7:50 PM
Data refreshes hourly during market hours. Next update: 7:50 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SBC showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Yoshiyuki Aikawa
SELL
4422900 shares
2026-03-06
Top Rated Consulting Services Stocks
Top-rated stocks in Consulting Services by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
EFX
Equifax Inc |
BUY
23 analysts |
$237 | 53 HOLD |
|
VRSK
Verisk Analytics Inc |
HOLD
18 analysts |
$230 | 61 BUY |
|
HURN
Huron Consulting Group I… |
STRONG BUY
5 analysts |
$216 | 55 HOLD |
|
BAH
Booz Allen Hamilton Hold… |
HOLD
14 analysts |
$107 | 60 BUY |
|
ICFI
ICF International Inc |
BUY
5 analysts |
$105 | 56 HOLD |
